|Bid||0.0680 x 0|
|Ask||0.0670 x 0|
|Day's range||0.0670 - 0.0690|
|52-week range||0.0220 - 0.1500|
|Beta (5Y monthly)||0.97|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
In 2016, Yatomi-Clarke Lee was appointed CEO of Prescient Therapeutics Limited (ASX:PTX). First, this article will...
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big...
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...